Page 71«..1020..70717273..8090..»

Pfizer’s Velsipity heading for NHS use in ulcerative colitis – pharmaphorum

Posted: Published on March 15th, 2024

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizers once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new guidance emerged on the same day that Velsipity (etrasimod) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as a treatment for moderately to severely active UC, a few weeks after it was cleared by the European Commission. Continue reading →

Posted in Ulcerative Colitis | Comments Off on Pfizer’s Velsipity heading for NHS use in ulcerative colitis – pharmaphorum

25000 people to benefit after NICE recommends new ulcerative colitis treatment – NICE

Posted: Published on March 15th, 2024

Thousands of people could be set to benefit after NICE today (Monday, 11 March) recommended a new one-a-day pill as an option for treating severe ulcerative colitis. NICEs final guidance on etrasimod (also known as Velsipity and made by Pfizer) is being published on the same day that the treatment was granted a licence by the Medicines and Healthcare Products Regulatory Agency (MHRA). Just over 25,000 people in England are eligible to receive the new treatment, which was evaluated using a simpler technology appraisal process. Continue reading →

Posted in Ulcerative Colitis | Comments Off on 25000 people to benefit after NICE recommends new ulcerative colitis treatment – NICE

NICE recommends new ulcerative colitis treatment for NHS use – Nursing Times

Posted: Published on March 15th, 2024

A new once-a-day pill has been recommended as an option for treating severe ulcerative colitis in England, with thousands of patients set to be eligible. The National Institute for Health and Care Excellence (NICE) has published final guidance backing the treatment etrasimod (Velsipity) We are determined to continue getting the best care to patients fast Helen Knight The move, on Monday, came on the same day that etrasimod was granted a licence by the Medicines and Healthcare Products Regulatory Agency (MHRA). Continue reading →

Posted in Ulcerative Colitis | Comments Off on NICE recommends new ulcerative colitis treatment for NHS use – Nursing Times

EU Commission Okays Pfizer’s VELSIPITY for Severe Ulcerative Colitis – Mirage News

Posted: Published on March 15th, 2024

Pfizer Inc. Continue reading →

Posted in Ulcerative Colitis | Comments Off on EU Commission Okays Pfizer’s VELSIPITY for Severe Ulcerative Colitis – Mirage News

EPA curbs toxic ethylene oxide used to sterilize medical devices – The Washington Post – The Washington Post

Posted: Published on March 15th, 2024

The Environmental Protection Agency on Thursday announced tougher limits on a cancer-causing gas used to sterilize medical equipment, a move aimed at helping disadvantaged communities across the country reduce their exposure to a toxic pollutant. Some environmental and public health advocates criticized the final rule as too weak, saying it would not adequately protect low-income and minority communities that are disproportionately affected. At the same time, the medical device industry warned that the rule could disrupt the supply of safe medical equipment at hospitals and clinics nationwide Continue reading →

Posted in Medical Technology | Comments Off on EPA curbs toxic ethylene oxide used to sterilize medical devices – The Washington Post – The Washington Post

Huawei Unveils Medical Technology Digitalization Solution at MWC Barcelona 2024 – The Healthcare Technology Report.

Posted: Published on March 15th, 2024

Huawei unveiled its groundbreaking Medical Technology Digitalization Solution at MWC Barcelona 2024, signaling a pivotal move in leading the digital evolution of the healthcare sector. Continue reading →

Posted in Medical Technology | Comments Off on Huawei Unveils Medical Technology Digitalization Solution at MWC Barcelona 2024 – The Healthcare Technology Report.

BioHive to launch HealthTech Hub Chapter to empower medical innovation and disrupt healthcare – Utah Business – Utah Business

Posted: Published on March 15th, 2024

Salt Lake CityBioHive, a nonprofit public-private partnership dedicated to enhancing Utahs life science and healthcare innovation ecosystem, will launch HealthTech Hub, a new BioHive chapter that empowers the states science and technology communities to help improve medical innovation and disrupt healthcare. The group will convene to explore innovative topics, provide thought leadership, and create opportunities for collaboration and sector crossover Continue reading →

Posted in Medical Technology | Comments Off on BioHive to launch HealthTech Hub Chapter to empower medical innovation and disrupt healthcare – Utah Business – Utah Business

OSI Systems Receives $15 Million Order for Innovative Medical Tech Components – The Bakersfield Californian

Posted: Published on March 15th, 2024

State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington Washington D.C. Continue reading →

Posted in Medical Technology | Comments Off on OSI Systems Receives $15 Million Order for Innovative Medical Tech Components – The Bakersfield Californian

ONWARD Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial … – TradingView

Posted: Published on March 15th, 2024

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company expects to commercialize its ARC-EX System and commence the Empower BP Pivotal Study for the ARC-IM System in 2024 Company ended 2023 with EUR 29.8M in cash; Q4 cash burn was EUR 7M; cash runway guidance reaffirmed through year-end 2024 Company reaffirms guidance and is highly confident the FDA submission for its ARC-EX System will occur in 1H 2024 Company expects to advance clinical and development activities for its unique ARC-BCITM brain-computer interface therapy EINDHOVEN, the Netherlands, March 15,2024 (GLOBE NEWSWIRE) ONWARD Medical N.V. ONWD, the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today reaffirms previous cash guidance, shares its strategic priorities for 2024, and releases its unaudited Q4 financial highlights Continue reading →

Posted in Medical Technology | Comments Off on ONWARD Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial … – TradingView

Medical Biomimetics Market Size is projected to reach USD 54.25 billion by 2031, growing at a CAGR of 6.5%: Straits … – GlobeNewswire

Posted: Published on March 15th, 2024

New York, United States, March 14, 2024 (GLOBE NEWSWIRE) -- Medical biomimetics, also known as biomimicry or bioinspired technology, is a field that creates and develops novel medical treatments, systems, and technologies using natural inspiration. Continue reading →

Posted in Medical Technology | Comments Off on Medical Biomimetics Market Size is projected to reach USD 54.25 billion by 2031, growing at a CAGR of 6.5%: Straits … – GlobeNewswire

Page 71«..1020..70717273..8090..»